Adjuvant and Neoadjuvant Therapy in Melanoma R. Amaria, MD Assistant Professor, Melanoma Medical Oncology 1/31/2015 • Adjuvant therapy: additional cancer treatment given…
RANDOMIZED PHASE II TRIAL COMPARING FOLFIRINOX (5FU/LEUCOVORIN, IRINOTECAN AND OXALIPLATIN) VS GEMCITABINE AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA…
New treatment approaches in Hepatocellular Carcinoma Dr. Francesco Caponigro Istituto Tumori Napoli Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related…
RANDOMIZED PHASE II TRIAL COMPARING FOLFIRINOX (5FU/LEUCOVORIN, IRINOTECAN AND OXALIPLATIN) VS GEMCITABINE AS FIRST-LINE TREATMENT FOR METASTATIC PANCREATIC ADENOCARCINOMA…